These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 444546)

  • 1. The reversible thiol-disulphide exchange of trypsin and chymotrypsinogen with a tumour-derived inhibitor. Kinetic data obtained with fluorescein-labelled polymeric collagen fibrils and casein as substrates.
    Steven FS; Podrazký V
    Biochim Biophys Acta; 1979 May; 568(1):49-58. PubMed ID: 444546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of a trypsin-dependent neutral protease and its inhibitor found in tumour cells. Analysis of complex kinetic data involved in a thiol-disulphide exchange mechanism.
    Steven FS; Podrazký V; Itzhaki S
    Biochim Biophys Acta; 1978 May; 524(1):170-82. PubMed ID: 656442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the inhibition of trypsin by thiols. The mechanism of enzyme-inhibitor complex formation.
    Steven FS; Podrazký V
    Eur J Biochem; 1978 Feb; 83(1):155-61. PubMed ID: 627206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of trypsin and chymotrypsin by thiols. Biphasic kinetics of reactivation and inhibition induced by sodium periodate addition.
    Steven FS; Al-Habib A
    Biochim Biophys Acta; 1979 Jun; 568(2):408-15. PubMed ID: 226148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A trypsin-like neutral protease on Ehrlich ascites cell surfaces: its role in the activation of tumour-cell zymogen of collagenase.
    Steven FS; Griffin MM; Itzhaki S; Al-Habib A
    Br J Cancer; 1980 Nov; 42(5):712-21. PubMed ID: 6257267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human-polymorphonuclear-leucocyte neutral protease and its inhibitor. Studies with fluorescein-labelled polymeric collagen fibrils as a substrate.
    Steven FS; Milsom DW; Hunter JA
    Eur J Biochem; 1976 Aug; 67(1):165-9. PubMed ID: 964237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the presence of a trypsin inhibitor within rabbit and mouse tumour cells.
    Steven FS; Podrazky V; Itzhaki S
    Biochim Biophys Acta; 1977 Jul; 483(1):211-4. PubMed ID: 880306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neutral protease in rheumatoid synovial fluid capable of attacking the telopeptide regions of polymeric collagen fibrils.
    Steven FS; Torre-Blanco A; Hunter JA
    Biochim Biophys Acta; 1975 Sep; 405(1):188-200. PubMed ID: 1236747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probes of the mechanism of zymogen catalysis.
    Lonsdale-Eccles JD; Neurath H; Walsh KA
    Biochemistry; 1978 Jul; 17(14):2805-9. PubMed ID: 687564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold-containing drugs and the control of proteolytic enzymes.
    Rohozková D; Steven FS
    Br J Pharmacol; 1983 May; 79(1):181-9. PubMed ID: 6871542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ala226 to Gly and Ser189 to Asp mutations convert rat chymotrypsin B to a trypsin-like protease.
    Jelinek B; Antal J; Venekei I; Gráf L
    Protein Eng Des Sel; 2004 Feb; 17(2):127-31. PubMed ID: 15047908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescein thiocarbamoyl-kappa-casein assay for the specific testing of milk-clotting proteases.
    Ageitos JM; Vallejo JA; Poza M; Villa TG
    J Dairy Sci; 2006 Oct; 89(10):3770-7. PubMed ID: 16960051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition properties of Sepharose-bound trypsin and a protease on the surface of Ehrlich ascites tumour cells.
    Steven FS; Griffin MM; Itzhaki GS; Al-Habib A
    Biochim Biophys Acta; 1981 Aug; 660(2):333-40. PubMed ID: 6269636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specificity and kinetic properties of trypsin ethylated at the binding site.
    Ben Avraham R; Shalitin Y
    FEBS Lett; 1985 Jan; 180(2):239-42. PubMed ID: 3967765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zymogen activation in a reconstituted pancreatic acinar cell system.
    Thrower EC; Diaz de Villalvilla AP; Kolodecik TR; Gorelick FS
    Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G894-902. PubMed ID: 16339296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen bonds in serine proteinases and their complexes with protein proteinase inhibitors. Proton nuclear magnetic resonance studies.
    Markley JL
    Biochemistry; 1978 Oct; 17(22):4648-56. PubMed ID: 569493
    [No Abstract]   [Full Text] [Related]  

  • 17. Polymeric collagen fibrils. An example of substrate-mediated steric obstruction of enzymic digestion.
    Steven FS
    Biochim Biophys Acta; 1976 Nov; 452(1):151-60. PubMed ID: 186122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the activation of bovine chymotrypsinogen A. Preparation of alanine-neochymotrypsinogen and its activation to alpha-chymotrypsin.
    Sharma SK; Hopkins TR
    Biochim Biophys Acta; 1978 Dec; 527(2):465-71. PubMed ID: 569499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of Ca2+-activated protease specific for the intermediate-sized filament protein vimentin in Ehrlich-ascites-tumour cells.
    Nelson WJ; Traub P
    Eur J Biochem; 1981 May; 116(1):51-7. PubMed ID: 7018903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of some thiol compounds upon trypsin, chymotrypsin and chymotrypsinogen.
    PETERS RA; WAKELIN RW
    Biochem J; 1948; 42(1):xvi. PubMed ID: 18934541
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.